Literature DB >> 9011620

Differences between outward currents of human atrial and subepicardial ventricular myocytes.

G J Amos1, E Wettwer, F Metzger, Q Li, H M Himmel, U Ravens.   

Abstract

1. Outward currents were studied in myocytes isolated from human atrial and subepicardial ventricular myocardium using the whole-cell voltage clamp technique at 22 degrees C. The Na+ current was inactivated with prepulses to -40 mV and the Ca2+ current was eliminated by both reducing extracellular [Ca2+] to 0.5 mM and addition of 100 microM CdCl2 to the bath solution. 2. In human myocytes, three different outward currents were observed. A slowly inactivating sustained outward current, I(so), was found in atrial but not ventricular myocytes. A rapidly inactivating outward current, I(to), of similar current density was observed in cells from the two tissues. An additional uncharacterized non-inactivating background current of similar size was observed in atrial and in ventricular myocytes. 3. I(to) and I(so) could be differentiated in atrial myocytes by their different kinetics and potential dependence of inactivation, and their different sensitivities to block by 4-amino-pyridine, suggesting that two individual channel types were involved. 4. In atrial cells, inactivation of I(to) was more rapid and steady-state inactivation occurred at more negative membrane potentials than in ventricular cells. Furthermore, the recovery of I(to) from inactivation was slower and without overshoot in atrial myocytes. In addition, 4-aminopyridine-induced block of I(to) was more efficient in atrial than in ventricular cells. These observations suggest that the channels responsible for atrial and ventricular I(to) were not identical. 5. We conclude that the differences in outward currents substantially contribute to the particular shapes of human atrial and ventricular action potentials. The existence of I(so) in atrial cells only provides a clinically interesting target for anti-arrhythmic drug action, since blockers of I(so) would selectively prolong the atrial refractory period, leaving ventricular refractoriness unaltered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9011620      PMCID: PMC1158757          DOI: 10.1113/jphysiol.1996.sp021194

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  38 in total

1.  Electrophysiological study of human heart muscle.

Authors:  W TRAUTWEIN; D G KASSEBAUM; R M NELSON
Journal:  Circ Res       Date:  1962-03       Impact factor: 17.367

2.  Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle.

Authors:  M M Tamkun; K M Knoth; J A Walbridge; H Kroemer; D M Roden; D M Glover
Journal:  FASEB J       Date:  1991-03-01       Impact factor: 5.191

3.  Ionic basis of the different action potential configurations of single guinea-pig atrial and ventricular myocytes.

Authors:  J R Hume; A Uehara
Journal:  J Physiol       Date:  1985-11       Impact factor: 5.182

Review 4.  Potassium channel toxins.

Authors:  P N Strong
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

5.  Two types of transient outward currents in adult human atrial cells.

Authors:  D Escande; A Coulombe; J F Faivre; E Deroubaix; E Coraboeuf
Journal:  Am J Physiol       Date:  1987-01

6.  Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists.

Authors:  M C Sanguinetti; R S Kass
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

7.  Electrophysiological properties of diseased human atrium. I. Low diastolic potential and altered cellular response to potassium.

Authors:  R E Ten Eick; D H Singer
Journal:  Circ Res       Date:  1979-04       Impact factor: 17.367

8.  Contributions of a transient outward current to repolarization in human atrium.

Authors:  E F Shibata; T Drury; H Refsum; V Aldrete; W Giles
Journal:  Am J Physiol       Date:  1989-12

9.  Two stable levels of diastolic potential at physiological K+ concentrations in human ventricular myocardial cells.

Authors:  J R McCullough; W T Chua; H H Rasmussen; R E Ten Eick; D H Singer
Journal:  Circ Res       Date:  1990-01       Impact factor: 17.367

10.  Cloning and expression of a human voltage-gated potassium channel. A novel member of the RCK potassium channel family.

Authors:  A Grupe; K H Schröter; J P Ruppersberg; M Stocker; T Drewes; S Beckh; O Pongs
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  64 in total

1.  The sulphonylurea glibenclamide inhibits voltage dependent potassium currents in human atrial and ventricular myocytes.

Authors:  P Schaffer; B Pelzmann; E Bernhart; P Lang; H Mächler; B Rigler; B Koidl
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 2.  Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium.

Authors:  J M Nerbonne
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

3.  Functional Characterization of Human Stem Cell-Derived Cardiomyocytes.

Authors:  Glenn E Kirsch; Carlos A Obejero-Paz; Andrew Bruening-Wright
Journal:  Curr Protoc Pharmacol       Date:  2014

4.  Differential Expression and Remodeling of Transient Outward Potassium Currents in Human Left Ventricles.

Authors:  Eric K Johnson; Steven J Springer; Wei Wang; Edward J Dranoff; Yan Zhang; Evelyn M Kanter; Kathryn A Yamada; Jeanne M Nerbonne
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-01

Review 5.  [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].

Authors:  U Ravens; E Wettwer; U Schotten; R Wessel; D Dobrev
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

6.  Ligand binding to the voltage-gated Kv1.5 potassium channel in the open state--docking and computer simulations of a homology model.

Authors:  Martin Andér; Victor B Luzhkov; Johan Aqvist
Journal:  Biophys J       Date:  2007-09-28       Impact factor: 4.033

7.  K+ current changes account for the rate dependence of the action potential in the human atrial myocyte.

Authors:  Mary M Maleckar; Joseph L Greenstein; Wayne R Giles; Natalia A Trayanova
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-24       Impact factor: 4.733

8.  Is there a functional correlate of Kv1.5 in the ventricle of canine heart and what would it mean for the use of I(Kur) blockers?

Authors:  E Wettwer
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 9.  Is there a future for antiarrhythmic drug therapy?

Authors:  P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

10.  Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium.

Authors:  Mary M Maleckar; Joseph L Greenstein; Natalia A Trayanova; Wayne R Giles
Journal:  Prog Biophys Mol Biol       Date:  2009-01-30       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.